Stonegate Investment Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,002
| Closed | -$207K | – | 406 |
|
|
2024
Q2 | $207K | Buy |
1,002
+26
| +3% | +$5.37K | 0.01% | 328 |
|
|
2024
Q1 | $264K | Buy |
+976
| New | +$264K | 0.01% | 269 |
|
|
2023
Q4 | – | Sell |
-1,025
| Closed | -$201K | – | 344 |
|
|
2023
Q3 | $201K | Sell |
1,025
-141
| -12% | -$27.6K | 0.01% | 275 |
|
|
2023
Q2 | $245K | Buy |
1,166
+61
| +6% | +$12.8K | 0.01% | 272 |
|
|
2023
Q1 | $223K | Buy |
1,105
+85
| +8% | +$17.2K | 0.01% | 283 |
|
|
2022
Q4 | $222K | Sell |
1,020
-88
| -8% | -$19.2K | 0.01% | 280 |
|
|
2022
Q3 | $218K | Buy |
1,108
+112
| +11% | +$22K | 0.01% | 252 |
|
|
2022
Q2 | $213K | Buy |
996
+87
| +10% | +$18.6K | 0.01% | 260 |
|
|
2022
Q1 | $258K | Buy |
909
+244
| +37% | +$69.3K | 0.01% | 219 |
|
|
2021
Q4 | $251K | Buy |
+665
| New | +$251K | 0.01% | 228 |
|